Medtronic has initiated an exchange offer to acquire up to 225,361,295 shares of MiniMed, comprising 80.1% of its total outstanding shares. Currently, Medtronic owns approximately 89.86% of MiniMed shares. Upon completion of the exchange, Medtronic intends to relinquish its equity stake in MiniMed, marking a significant milestone in MiniMed's journey towards independence.
Company Information
Company
Medtronic plc
Location
Minneapolis, Minnesota, United States
About
Medtronic plc is the leading global healthcare technology company headquartered in Dublin, Ireland. The company's mission is to alleviate pain, restore health, and extend life by delivering innovative technologies that transform the lives of people around the world. With a global team of 95,000+ passionate people in over 150 countries, Medtronic's technologies and therapies treat 70 health conditions.
Don't miss Medtronic plc's next move
Get an email the moment Medtronic plc makes an acquisition, hires an exec, or expands, usually minutes after it happens.
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed
Frequently asked
Who acquired MiniMed?
MiniMed was acquired by Medtronic plc, based in Minneapolis. The deal was reported on September 14, 2026. Medtronic plc is the leading global healthcare technology company headquartered in Dublin, Ireland. Medtronic plc is publicly traded (MDT) and operates in Manufacturing.
When did Medtronic plc acquire MiniMed?
Medtronic plc's acquisition of MiniMed was reported on September 14, 2026. Medtronic has initiated an exchange offer to acquire up to 225,361,295 shares of MiniMed, comprising 80.1% of its total outstanding shares. Currently, Medtronic owns approximately 89.86% of MiniMed shares. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does MiniMed do?
MiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in 80 countries. It is publicly traded (MMED), operating in Biotechnology, and is based in Los Angeles.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.